The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Nobilis IB Ma5

. Lyophilisate for solution

Intervet Ireland LimitedVPA10996/136/001

Main Information

Trade NameNobilis IB Ma5
Active SubstancesLive attenuated IB virus strain Ma5
Dosage FormLyophilisate for solution
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/136/001

Group Information

ATC CodeQI01AD07 avian infectious bronchitis virus
Therapeutic ClassImmunological - Live Vaccine


Licence Issued19/02/2003
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back